FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula (I), where each R1, R2 and R3 is independently selected from a group comprising H, OH, F, Cl, Br, a methoxy group and an ethoxy group; or R1 and R2 together form -OCH2O-, and R3 is selected from a group comprising H, OH, methoxy group, ethoxy group and halogens; R4 denotes OH or o-acetoxybenzoyloxy nicotinoyloxy or iso-nicotinoyloxy; R5 denotes or , and at least one of R1, R2 and R3 is not hydrogen.
EFFECT: method for synthesis of a compound of formula (I) and use of the compound of formula (I) in preparing medicinal agents for preventing or treating cerebrovascular diseases.
17 cl, 14 tbl, 5 dwg, 12 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIBACTERIAL AGENT | 2000 |
|
RU2269525C2 |
TRIPEPTIDE COMPOUND, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2015 |
|
RU2685709C2 |
GLUCOCORTICOIDS CONNECTED BY MEANS OF AROMATIC LINKER IN POSITION 21 TO NITRATE ESTERS, AND THEIR APPLICATION IN OPTHALMOLOGY | 2009 |
|
RU2501804C2 |
FLAVONOID COMPOUNDS AND USE THEREOF | 2006 |
|
RU2431634C2 |
NOVEL CYCLOHEXANE DERIVATIVE, PRODRUG AND SALT THEREOF AND DIABETES THERAPEUTIC AGENT CONTAINING SAID COMPOUNDS | 2005 |
|
RU2394015C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING CARBAMOYLOXYARYLALCANOYLARYLPIPERAZINE COMPOUND | 2011 |
|
RU2630619C2 |
CARBOXAMIDE DERIVATIVES OF PYRROLIDINE OR PIPERIDINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF INHIBITION OF PLATELET AGGREGATION | 1997 |
|
RU2194038C2 |
19,11-BRIDGED OVER 4-ESTRENES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS | 1993 |
|
RU2157814C2 |
DERIVATIVES OF NOSCAPINE (VARIANTS), COMBINATORY AND FOCUSED LIBRARIES, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PREPARING (VARIANTS) AND USING | 2006 |
|
RU2304584C1 |
COMPOSITIONS FOR TREATMENT OF HYPERTENSION AND/OR FIBROSIS | 2017 |
|
RU2752088C1 |
Authors
Dates
2011-06-20—Published
2007-05-14—Filed